As seen in NSCLC, another adult cancer where BRG1 loss is a progressive event, EMT is associated with poorer prognosis and disease progression (Tsoukalas et al., 2017; Mahmood et al., 2017). This evidence concerns the gene SMARCA4 and cancer.